"10.1371_journal.pone.0075507","plos one","2013-10-04T00:00:00Z","Zhengtao Chu; Shadi Abu-Baker; Mary B Palascak; Syed A Ahmad; Robert S Franco; Xiaoyang Qi","Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America; Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America; Division of Human Genetics, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America","Conceived and designed the experiments: ZC SAA RSF XQ. Performed the experiments: ZC SAB MBP XQ. Analyzed the data: ZC SAB MBP SAA RSF XQ. Contributed reagents/materials/analysis tools: ZC RSF XQ. Wrote the paper: ZC SAB RSF XQ. Edited and approved the manuscript: ZC SAB MBP SAA RSF XQ.","The authors have declared the following interests: Xiaoyang Qi in listed as an inventor on the patent for the technology (SapC-DOPS) that is the subject of this research. Consistent with current Cincinnati Children’s Hospital Medical Center policies, the development and commercialization of this technology has been licensed to Bexion Pharmaceuticals, LLC, in which Dr. Qi holds a minor (<5%) equity interest. Dr. Qi is an inventor of scientific research that is in the pre-clinical stage for Bexion Pharmaceuticals. At this time, Bexion Pharmaceuticals does not offer any marketable treatments or drugs. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2013","10","Zhengtao Chu","ZC",6,TRUE,4,4,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
